Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genomics One Corporation was a Canadian biotechnology company specializing in the development and commercialization of proprietary genomic technologies and tools. The company was best known for its TrueBlue cloning system, which utilized a unique color-based selection method to improve the efficiency of DNA cloning and sequencing. Based in Laval, Quebec, Genomics One provided products and services to academic and industrial researchers to facilitate large-scale genomic analysis. Its product portfolio included high-quality genomic libraries and specialized molecular biology reagents. Despite its innovative technology, the company faced significant financial challenges in the mid-2000s, leading to its delisting from the Toronto Stock Exchange and eventual cessation of operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genomics One.